Medplus Health Services
BSE 543427 · ISIN INE804L01022
9 stories, newest first.
- MedPlus to host earnings call on October 28, 2026 for Q2/H1 FY2026 results
- MedPlus management addressed Supreme Court scrutiny on drug pricing and hospital markups, saying retail pharmacy margins remain low and the issue mainly affects hospitals and manufacturers
- Government capped margins on non-scheduled anti-cancer drugs at 30% of MRP; MedPlus CEO said this has negligible impact on the company
- Promoter creates additional pledge of 16,00,000 shares to maintain NCD security cover
- Promoter creates additional pledge over 5,50,000 shares to maintain NCD security cover
- Promoter creates additional pledge of 16,00,000 equity shares to maintain NCD security cover
- Promoter Agilemed creates additional pledge over 5,50,000 shares
- CareEdge reaffirms CARE A; Stable on Rs 236.00 crore long-term and CARE A1 on Rs 14.00 crore short-term facilities of Optival Health Solutions
- Board to Consider Q2 & H1 FY27 Unaudited Results on October 27, 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.